Using millions of hydroxyapatite (HA) particles around an implant, the biological activity of a common osteoporosis drug can be significantly improved. This improvement is reported as increased amount of bone formation around the implant with HA and better mechanical integration of the implant with the bone compared with the implant that did not have HA particles. Better outcome implies a reduction in implant failures in hip fracture patients and increased life quality with lower mortality.
Menu